Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1979 Jan;65(1):35–41. doi: 10.1111/j.1476-5381.1979.tb17331.x

Effects of modulators of arachidonic acid metabolism on the synthesis and release of slow-reacting substance of anaphylaxis.

J F Burka, R J Flower
PMCID: PMC1668473  PMID: 367476

Abstract

1 Slow-reacting substance of anaphylaxis (SRS-A) was released in the peritoneum of passively sensitized rats challenged with ovalbumin and from rat isolated peritoneal cells stimulated with calcium ionophore A23187. 2 Both monocytes (macrophages) and mast cells appear to be involved in the synthesis and release of SRS-A. 3 The immunological release of SRS-A in vivo is enhanced by indomethacin and inhibited by dexamethasone, mepacrine, 1-phenyl-3-pyrazolidone (1-P-3-P), and methylimidazole. 4 SRS-A release induced by A23187 in vitro is inhibited by dexamethasone, indomethacin 1-P-3-P, eicosatetraynoic acid (ETA) and 15-hydroperoxy arachidonic acid. The inhibition induced by dexamethasone, indomethacin and 1-P-3-P is reduced by an increase in the calcium concentration from 1 mM to 5 mM, whereas the inhibition induced by ETA is increased. 5 The results suggest that a lipoxygenase is important in the synthesis and release by SRS-A.

Full text

PDF
36

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BROCKLEHURST W. E. The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock. J Physiol. 1960 Jun;151:416–435. doi: 10.1113/jphysiol.1960.sp006449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bach M. K., Brashler J. R., Gorman R. R. On the structure of slow reacting substance of anaphylaxis: evidence of biosynthesis from arachidonic acid. Prostaglandins. 1977 Jul;14(1):21–38. doi: 10.1016/0090-6980(77)90154-x. [DOI] [PubMed] [Google Scholar]
  3. Bach M. K., Brashler J. R. In vivo and in vitro production of a slow reacting substance in the rat upon treatment with calcium ionophores. J Immunol. 1974 Dec;113(6):2040–2044. [PubMed] [Google Scholar]
  4. Blackwell G. J., Flower R. J. 1-Phenyl-3-pyrazolidone: an inhibitor of arachidonate oxidation in lung and platelets [proceedings]. Br J Pharmacol. 1978 Jun;63(2):360P–360P. [PMC free article] [PubMed] [Google Scholar]
  5. Blackwell G. J., Flower R. J., Nijkamp F. P., Vane J. R. Phospholipase A2 activity of guinea-pig isolated perfused lungs: stimulation, and inhibition by anti-inflammatory steroids. Br J Pharmacol. 1978 Jan;62(1):79–89. doi: 10.1111/j.1476-5381.1978.tb07009.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Burka J. F., Eyre P. Modulation of the formation and release of bovine SRS-A in vitro by several anti-anaphylactic drugs. Int Arch Allergy Appl Immunol. 1975;49(6):774–781. doi: 10.1159/000231461. [DOI] [PubMed] [Google Scholar]
  7. Burka J. F., Garland L. G. A possible modulatory role for prostacyclin (PGI2) INIgGa-induced release of slow-reacting substance of anaphylaxis in rats. Br J Pharmacol. 1977 Dec;61(4):697–699. doi: 10.1111/j.1476-5381.1977.tb07564.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Engineer D. M., Niederhauser U., Piper P. J., Sirois P. Release of mediators of anaphylaxis: inhibition of prostaglandin synthesis and the modification of release of slow reacting substance of anaphylaxis and histamine. Br J Pharmacol. 1978 Jan;62(1):61–66. doi: 10.1111/j.1476-5381.1978.tb07006.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Foreman J. C., Mongar J. L., Gomperts B. D. Calcium ionophores and movement of calcium ions following the physiological stimulus to a secretory process. Nature. 1973 Oct 5;245(5423):249–251. doi: 10.1038/245249a0. [DOI] [PubMed] [Google Scholar]
  10. Gryglewski R. J., Bunting S., Moncada S., Flower R. J., Vane J. R. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins. 1976 Nov;12(5):685–713. doi: 10.1016/0090-6980(76)90047-2. [DOI] [PubMed] [Google Scholar]
  11. Hamberg M., Samuelsson B. Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci U S A. 1974 Sep;71(9):3400–3404. doi: 10.1073/pnas.71.9.3400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hook W. A., Schiffmann E., Aswanikumar S., Siraganian R. P. Histamine release by chemotactic, formyl methionine-containing peptides. J Immunol. 1976 Aug;117(2):594–596. [PubMed] [Google Scholar]
  13. Jakschik B. A., Falkenhein S., Parker C. W. Precursor role of arachidonic acid in release of slow reacting substance from rat basophilic leukemia cells. Proc Natl Acad Sci U S A. 1977 Oct;74(10):4577–4581. doi: 10.1073/pnas.74.10.4577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jakschik B. A., Kulczycki A., Jr, MacDonald H. H., Parker C. W. Release of slow reacting substance (SRS) from rat basophilic leukemia (RBL-1) cells. J Immunol. 1977 Aug;119(2):618–622. [PubMed] [Google Scholar]
  15. Kaliner M., Austen K. F. A sequence of biochemical events in the antigen-induced release of chemical mediators from sensitized human lung tissue. J Exp Med. 1973 Nov 1;138(5):1077–1094. doi: 10.1084/jem.138.5.1077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lewis G. P., Whittle B. J. The inhibition of histamine release from rat peritoneal mast cells by non-steroid anti-inflammatory drugs and its reversal by calcium. Br J Pharmacol. 1977 Oct;61(2):229–235. doi: 10.1111/j.1476-5381.1977.tb08409.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lichtenstein L. M., Margolis S. Histamine release in vitro: inhibition by catecholamines and methylxanthines. Science. 1968 Aug 30;161(3844):902–903. doi: 10.1126/science.161.3844.902. [DOI] [PubMed] [Google Scholar]
  18. Lichtenstein L. M. The mechanism of basophil histamine release induced by antigen and by the calcium ionophore A23187. J Immunol. 1975 Jun;114(6):1692–1699. [PubMed] [Google Scholar]
  19. Liebig R., Bernauer W., Peskar B. A. Release of prostaglandins, a prostaglandin metabolite, slow-reacting substance and histamine from anaphylactic lungs, and its modification by catecholamines. Naunyn Schmiedebergs Arch Pharmacol. 1974;284(3):279–293. doi: 10.1007/BF00500347. [DOI] [PubMed] [Google Scholar]
  20. Moncada S., Bunting S., Mullane K., Thorogood P., Vane J. R., Raz A., Needleman P. Imidazole: a selective inhibitor of thromboxane synthetase. Prostaglandins. 1977 Apr;13(4):611–618. doi: 10.1016/0090-6980(77)90232-5. [DOI] [PubMed] [Google Scholar]
  21. Orange R. P. The formation and release of slow-reacting substance of anaphylaxis. Monogr Allergy. 1977;12:231–240. [PubMed] [Google Scholar]
  22. Orange R. P., Valentine M. D., Austen K. F. Antigen-induced release of slow reacting substance of anaphylaxis (SRS-A rat) in rats prepared with homologous antibody. J Exp Med. 1968 Apr 1;127(4):767–782. doi: 10.1084/jem.127.4.767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Siraganian P. A., Siraganian R. P. Basophil activation by concanavalin A: characteristics of the reaction. J Immunol. 1974 Jun;112(6):2117–2125. [PubMed] [Google Scholar]
  24. Tateson J. E., Moncada S., Vane J. R. Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets. Prostaglandins. 1977 Mar;13(3):389–397. doi: 10.1016/0090-6980(77)90019-3. [DOI] [PubMed] [Google Scholar]
  25. UVNAS B., THON I. L. Evidence for enzymatic histamine release from isolated rat mast cells. Exp Cell Res. 1961 Feb;23:45–57. doi: 10.1016/0014-4827(61)90062-3. [DOI] [PubMed] [Google Scholar]
  26. VANE J. R. A sensitive method for the assay of 5-hydroxytryptamine. Br J Pharmacol Chemother. 1957 Sep;12(3):344–349. doi: 10.1111/j.1476-5381.1957.tb00146.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232–235. doi: 10.1038/newbio231232a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES